SPP1 and lipoprotein glomerulopathy: In a cohort of biopsy-proven glomerulopathy, IgAN, membranous nephropathy, and LN, OPN had an accuracy of 87% in distinguishing IgAN from other glomerulopathies, and thus appears to be a valuable biomarker [66].